Allena Stock Valuation

ALNA
 Stock
  

USD 0.026  0.0007  2.77%   

Do you wonder what the value of Allena Pharmaceuticals is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Allena Pharmaceuticals, is its stock price multiplied by the total number of shares outstanding, calculating Allena Pharmaceuticals' enterprise value requires a different approach. It uses Allena Pharmaceuticals' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Allena Pharmaceuticals seems to be undervalued based on Macroaxis valuation methodology. Our model approximates the value of Allena Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of (278.14) %, current valuation of 8.46 M, and Shares Owned by Insiders of 1.15 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Allena Pharmaceuticals Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Allena Pharmaceuticals's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today 0.026
Please note that Allena Pharmaceuticals' price fluctuation is abnormally volatile at this time. Calculation of the real value of Allena Pharmaceuticals is based on 3 months time horizon. Increasing Allena Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Allena Pharmaceuticals is useful when determining the fair value of the Allena stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Allena Pharmaceuticals. Since Allena Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Allena Stock. However, Allena Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
1.28
Real Value
12.14
Upside
Estimating the potential upside or downside of Allena Pharmaceuticals helps investors to forecast how Allena stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Allena Pharmaceuticals more accurately as focusing exclusively on Allena Pharmaceuticals' fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimated ValueHigh
0.000.0310.89
Details
4 Analysts
Consensus
LowTarget PriceHigh
1.255.0611.00
Details

Allena Pharmaceuticals Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Allena Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Allena Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allena Pharmaceuticals competition to find correlations between indicators driving Allena Pharmaceuticals's intrinsic value. More Info.
Allena Pharmaceuticals is number one stock in price to book category among related companies. It is number one stock in beta category among related companies totaling about  8.35  of Beta per Price to Book. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Allena Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Allena Pharmaceuticals' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Allena Pharmaceuticals' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Allena Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Allena Pharmaceuticals and how it compares across the competition.

About Allena Pharmaceuticals Valuation

The stock valuation mechanism determines the current worth of Allena Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Allena Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Allena Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Allena Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Allena Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Allena Pharmaceuticals. We calculate exposure to Allena Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Allena Pharmaceuticals's related companies.
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts. Allena Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NMS Exchange. It employs 17 people.

Allena Pharmaceuticals Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Allena Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio0.88
Enterprise Value To Ebitda-0.18
Please continue to Trending Equities. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Tools for Allena Stock

When running Allena Pharmaceuticals price analysis, check to measure Allena Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allena Pharmaceuticals is operating at the current time. Most of Allena Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Allena Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Allena Pharmaceuticals' price. Additionally, you may evaluate how the addition of Allena Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go